Literature DB >> 22415839

Derivation of cerebellar neurons from human pluripotent stem cells.

Slaven Erceg1, Dunja Lukovic, Victoria Moreno-Manzano, Miodrag Stojkovic, Shomi S Bhattacharya.   

Abstract

Here we provide a protocol for differentiation of human embryonic stem cells (hESC) into cerebellar neurons using a novel defined culture method. This protocol is based on the application of inductive signaling factors involved in the early patterning of the cerebellar region of the neural tube, followed by the application of factors responsible for cerebellar neuron specification. Human pluripotent stem cells are induced to form spherical embryonic-like structures called embryoid bodies (EBs) and neuroepithelial tube-like rosettes using defined chemical conditions. In the presence of FGF, Wnt, and RA signaling factors the rosettes were specified to OTX2-expressing cells. Further specification of derived cells involves application of BMP factors involved in early development of granule cell progenitors, followed by mitogens and neurotrophins. It typically takes 5 weeks to generate the functional cerebellar granule neurons. This protocol is feeder-free, applies human recombinant factors, and produces high yield of desired neurons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415839     DOI: 10.1002/9780470151808.sc01h05s20

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  15 in total

1.  Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.

Authors:  Claudia Compagnucci; Sabina Barresi; Stefania Petrini; Pierre Billuart; Giorgia Piccini; Pietro Chiurazzi; Paolo Alfieri; Enrico Bertini; Ginevra Zanni
Journal:  Stem Cells Transl Med       Date:  2016-05-09       Impact factor: 6.940

Review 2.  In vitro neurogenesis: development and functional implications of iPSC technology.

Authors:  Claudia Compagnucci; Monica Nizzardo; Stefania Corti; Ginevra Zanni; Enrico Bertini
Journal:  Cell Mol Life Sci       Date:  2013-11-20       Impact factor: 9.261

Review 3.  Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells.

Authors:  Kristen A Lemke; Alireza Aghayee; Randolph S Ashton
Journal:  Curr Opin Biotechnol       Date:  2017-06-09       Impact factor: 9.740

Review 4.  Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells.

Authors:  M Paulina Ordoñez; John W Steele
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

5.  Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats.

Authors:  Takashi Amemori; Jiri Ruzicka; Nataliya Romanyuk; Meena Jhanwar-Uniyal; Eva Sykova; Pavla Jendelova
Journal:  Stem Cell Res Ther       Date:  2015-12-22       Impact factor: 6.832

Review 6.  Probing disorders of the nervous system using reprogramming approaches.

Authors:  Justin K Ichida; Evangelos Kiskinis
Journal:  EMBO J       Date:  2015-04-29       Impact factor: 11.598

Review 7.  Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.

Authors:  Sarah Wiethoff; Charles Arber; Abi Li; Selina Wray; Henry Houlden; Rickie Patani
Journal:  J Neurogenet       Date:  2015-08-27       Impact factor: 1.250

Review 8.  Non-coding RNAs in pluripotency and neural differentiation of human pluripotent stem cells.

Authors:  Dunja Lukovic; Victoria Moreno-Manzano; Martin Klabusay; Miodrag Stojkovic; Shomi S Bhattacharya; Slaven Erceg
Journal:  Front Genet       Date:  2014-05-14       Impact factor: 4.599

Review 9.  Neural Conversion and Patterning of Human Pluripotent Stem Cells: A Developmental Perspective.

Authors:  Alexandra Zirra; Sarah Wiethoff; Rickie Patani
Journal:  Stem Cells Int       Date:  2016-03-16       Impact factor: 5.443

10.  High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform.

Authors:  Nienke R Wevers; Remko van Vught; Karlijn J Wilschut; Arnaud Nicolas; Chiwan Chiang; Henriette L Lanz; Sebastiaan J Trietsch; Jos Joore; Paul Vulto
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.